Provided by Tiger Trade Technology Pte. Ltd.

Crinetics Pharmaceuticals Inc.

84.69
0.0000
Post-market: 84.710.0167+0.02%19:30 EDT
Volume:2.02M
Turnover:170.83M
Market Cap:8.99B
PE:-16.84
High:84.77
Open:84.70
Low:84.69
Close:84.69
52wk High:84.80
52wk Low:29.63
Shares:106.10M
Float Shares:95.53M
Volume Ratio:0.53
T/O Rate:2.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.0290
EPS(LYR):-4.9500
ROE:-42.45%
ROA:-26.28%
PB:7.54
PE(LYR):-17.11

Loading ...

Vertex to Buy Crinetics for $85 Per Share in Cash, Valuing Deal at $10 Billion

Reuters
·
Jul 07

Crinetics Pharmaceuticals: Financing Supported by $4.5 Bln of Fully Committed Bridge Financing from Bank of America, Morgan Stanley Senior Funding

THOMSON REUTERS
·
Jul 07

Crinetics Pharmaceuticals: Deal Expected to be Accretive Vertex's to Non-gaap Operating Income in 2029

THOMSON REUTERS
·
Jul 07

Crinetics Pharmaceuticals Inc: Vertex Will Acquire Crinetics for $85.00 Per Share in Cash

THOMSON REUTERS
·
Jul 07

DLocal, Cypherpunk, BCE, LAC, Crinetics: Trending By Analysts

TIPRANKS
·
Jul 04

Sector Update: Healthcare

MT Newswires Live
·
Jul 03

Crinetics Pharmaceuticals Shares Rise After UBS Initiates Coverage

MT Newswires Live
·
Jul 03

UBS Initiates Coverage on Crinetics Pharmaceuticals With Buy Rating, $55 Price Target

MT Newswires Live
·
Jul 02

Crinetics Pharmaceuticals Initiated at Buy by UBS

Dow Jones
·
Jul 02

Crinetics initiated with a Buy at UBS

TIPRANKS
·
Jul 02

Analysts Are Bullish on Top Healthcare Stocks: Crinetics Pharmaceuticals (CRNX), Definium Therapeutics (DFTX)

TIPRANKS
·
Jun 29

Crinetics Pharmaceuticals shareholders elect three Class II directors at annual meeting

Reuters
·
Jun 23

Crinetics Pharmaceuticals (CRNX) Stock Could Be 56.5% Undervalued After ENDO 2026 Data

Simply Wall St.
·
Jun 19

Crinetics director Stephanie Okey disposes of 6,900 shares worth $247,127.44

Reuters
·
Jun 19

How New Atumelnant and PALSONIFY Data At Crinetics Pharmaceuticals (CRNX) Has Changed Its Investment Story

Simply Wall St.
·
Jun 17

Analysts Are Bullish on Top Healthcare Stocks: Crinetics Pharmaceuticals (CRNX), Pharvaris (PHVS)

TIPRANKS
·
Jun 16

Crinetics Pharmaceuticals Price Target Maintained With a $81.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 15

Crinetics Oral Drug Curbs Hormones, Lowers Steroid Use in Rare Disease Trial

MT Newswires Live
·
Jun 15

Crinetics presents full results from Phase 2 trial of atumelnant

TIPRANKS
·
Jun 15

Crinetics presents long-term data from program evaluating Palsonify

TIPRANKS
·
Jun 15